CVR: 10054974
Secondary names: COPENHAGEN MEDLAB LINA MEDICAL ApS
The financial health of LINA MEDICAL ApS shows significant volatility, with a concerning trend in profitability over recent years. Revenue peaked at 239.97 million DKK in 2022 but has since declined to 150.13 million DKK in 2025, while profits have fluctuated dramatically, resulting in losses of 10.6 million DKK in 2025 and 11.73 million DKK in 2023. Despite a relatively strong equity position of 13.88 million DKK in 2025, the company's declining margins and inconsistent profitability raise concerns about its operational efficiency and market position within the medical and dental instrument manufacturing industry. Overall, LINA MEDICAL ApS appears to be facing challenges that could impact its future growth trajectory.
AI-generated summary
Selskabets formål er handel og fabrikation af medicinske artikler samt hermed beslægtet virksomhed. Selskabets formål er endvidere at eje kapitalandele i andre selskaber samt stille sikkerhed, lån eller yde anden finansiel støtte til et sådant datterselskab.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 150.1 mio. | -10.6 mio. | 451.4 mio. | 13.9 mio. | 23 | |
Compared to 302 companies in Fremstilling af medicinske og dentale instrumenter samt udstyr hertil
Comparison is based on industry median values
Companies in the same industry and area
CVR 42640859
CVR 25704428
CVR 44141078
CVR 36578335
CVR 26094577
companydata.dk